It is additionally authorized for adults who will be overweight with a number of bodyweight-connected circumstances, like high hypertension or Form 2 diabetic issues (large blood sugar). In March of 2024, the FDA authorised a further indication for Wegovy—to decrease the risk of cardiovascular Loss of life, coronary heart attack, https://glp-1weightlossmed.com/product/wegovy/